Lifeboat Foundation

Guidance and recommendations for prostate cancer screening have changed over the years. While there is no standard screening test, doctors may use a prostate-specific antigen (PSA) test to help diagnose prostate cancer. Doctors may follow a positive PSA test with a prostate biopsy.

Most recommending bodies emphasize a shared decision-making (SDM) approach for prostate cancer screening by PSA testing. This strategy moves away from doctors making treatment decisions and instead relies on collaborative interactions between patients and healthcare teams.

Why do expert opinions on prostate cancer screening differ? This remains a complex question with a lot to unpack. First, we have limited treatment options for cancer that has already spread outside of the prostate. Thus, detecting these cases will often not improve health or prolong life. Second, many cases of slow-growing prostate cancer will never become life-threatening; detection of these cases can be considered overdiagnosis and may lead to anxiety, unnecessary treatment, and accompanying side effects. Unnecessary biopsies, which provide no additional value to patients and physicians in decision-making, can also come with complications such as bleeding and infection.

New research that helps explain the molecular processes involved in the painful autoimmune disease ankylosing spondylitis, or AS, may reduce the guessing game that health care providers currently play while attempting to treat the condition.

A team from Oregon Health & Science University and the VA Portland Health Care System has found a specific kind of AS treatment that is effective when used by patients who have a particular genetic mutation. Their study was published today in the journal Annals of the Rheumatic Diseases, and its findings could lead to more targeted, timely and patient-specific treatment recommendations.

“This is the first time research has shown that we might be able to use genetic markers to determine which therapy ankylosing spondylitis patients should receive,” said the study’s senior researcher, Ruth Napier, Ph.D., assistant professor of molecular microbiology and immunology, arthritis and rheumatic disease in the OHSU School of Medicine, and principal investigator with VA Portland. “These promising findings are encouraging. This is the first time I can say that I’m on the cusp of making a difference for patients with ankylosing spondylitis who seek relief.”

The number of kids being diagnosed with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) has risen sharply in recent decades, and a new study points to the common plastic additive bisphenol A (BPA) as a potential reason why.

BPA is used in a lot of plastics and plastic production processes, and can also be found inside food and drink cans. However, previous research has also linked it to health issues involving hormone disruption, including breast cancer and infertility.

In this new study, researchers from Rowan University and Rutgers University in the US looked at three groups of children: 66 with autism, 46 with ADHD, and 37 neurotypical kids. In particular, they analyzed the process of glucuronidation, a chemical process the body uses to clear out toxins within the blood through urine.

SUBSCRIBE TO DOCTORLY UNHINGED PODCAST!
https://doctorly.podlink.to/unhinged.

*Shop Favorite Skincare Products*
Shop My Shelf: https://shopmyshelf.us/shops/dermdoctor.
Amazon Favorites: https://www.amazon.com/shop/doctorly?tag=lifeboatfound-20.
20% Off Paula’s Choice: https://www.tkqlhce.com/click-100667849-15267262
Shop SkinBetter Science: https://skinbetter.pro/doctorly.

Continue reading “Artificial Intelligence Shaping the Future of Medicine” »

To listen to more of John Wheeler’s stories, go to the playlist: https://www.youtube.com/playlist?list=PLVV0r6CmEsFzVlqiUh95Q881umWUPjQbB

American physicist, John Wheeler (1911−2008), made seminal contributions to the theories of quantum gravity and nuclear fission, but is best known for coining the term ‘black holes’. A keen teacher and mentor, he was also a key figure in the Manhattan Project. [Listener: Ken Ford]

Continue reading “John Wheeler — Kurt Gödel and the Closed Time-like Line” »

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Continue reading “Higher HRV, Lower RHR: Potential Impacts For Weight Loss And Consistent Exercise Training” »

Aug 29 (Reuters) — Britain’s state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters.

Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England said on Tuesday hundreds of eligible patients treated with the immunotherapy, atezolizumab, were set to have “under the skin” injection, which will free up more time for cancer teams.

“This approval will not only allow us to deliver convenient and faster care for our patients, but will enable our teams to treat more patients throughout the day,” Dr Alexander Martin, a consultant oncologist at West Suffolk NHS Foundation Trust said.

Also, Silverchain has adopted Datos Health’s RPM platform as part of its virtual care delivery.

A recent study reports something strange: When mice with Alzheimer’s disease inhale menthol, their cognitive abilities improve. It seems the chemical compound can stop some of the damage done to the brain that’s usually associated with the disease.

In particular, researchers noticed a reduction in the interleukin-1-beta (IL-1β) protein, which helps to regulate the body’s inflammatory response – a response that can offer natural protection but one that leads to harm when it’s not controlled properly.

The team behind the study, which was published in April 2023, says it shows the potential for particular smells to be used as therapies for Alzheimer’s. If we can figure out which odors cause which brain and immune system responses, we can harness them to improve health.